You would expect a robust reply to such a forceful article targeting Biotron directly, and if I was an adjudicator of both the article and its response reply at the time, I would say, “only time will tell who is correct “. Well now the passage of time has happened, so who do you think is correct?. Biotron was set up to fund Australian research for possible commercialisation, clearly it has failed this with insufficient funding to continue with BIT225 and Covid, but Michelle still gets her salary plus increase.
Scripps Research study identifies existing drugs as potential COVID-19 therapies, page-69
-
- There are more pages in this discussion • 103 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $7.664K | 403.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1202498 | 5 |
View Market Depth
| Last trade - 13.42pm 27/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |